The present invention relates to a recombinant bacterium wherein said bacterium comprises an optogenetic interaction switch to control cellular functions, in particular wherein said bacterium is a recombinant gram-negative bacterium comprising a type III secretion system, wherein the activity of said type III secretion system is light-dependent, and to methods for controlling cellular functions in a bacterium using such an optogenetic interaction switch.

The present invention relates to a recombinant bacterium wherein said bacterium comprises an optogenetic interaction switch to control cellular functions, in particular wherein said bacterium is a recombinant gram-negative bacterium comprising a type III secretion system, wherein the activity of said type III secretion system is light-dependent, and to methods for controlling cellular functions in a bacterium using such an optogenetic interaction switch.

Methods for controlling plant pests are disclosed. In particular, insecticidal proteins having toxicity to Spodoptera insect pests are provided. Polynucleotides comprising codons optimized for expression in plants encoding the insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and polynucleotides encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.

Disclosed are compositions comprising a Gram negative needle tip protein and a translocator protein and methods of their use.

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO.

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO.

The present invention relates to probiotic compositions. More specifically, the present invention relates to probiotic compositions that are useful in reducing inflammation and/or that exhibit increased colonization or persistence in the gastrointestinal tract of a mammal.

The present invention relates to probiotic compositions. More specifically, the present invention relates to probiotic compositions that are useful in reducing inflammation and/or that exhibit increased colonization or persistence in the gastrointestinal tract of a mammal.

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic encoding a putative transporter protein of the MFS superfamily; and methods using said cell for the production of oligosaccharide(s), preferably an HMO.

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic encoding a putative transporter protein of the MFS superfamily; and methods using said cell for the production of oligosaccharide(s), preferably an HMO.